相关实验视频

Updated: Jun 9, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

来自两个不同平台的体质BRCA1/2致病变体的差异在上皮卵巢,输卵管和腹腔癌中的异常

Ji Hyun Kim1, Jun-Young Shin2, Seog-Yun Park2

  • 1Center for Gynecologic Cancer, National Cancer Center, Goyang, Korea.

Scientific reports
|October 29, 2024
PubMed
概括

下一代测序 (NGS) 平台在检测卵巢癌患者的BRCA1/BRCA2致病变体 (PV) 和可能的PV (LPV) 中显示了约12%的差异. 这凸显了需要仔细解释和交叉验证不同的遗传测试平台的需要.

关键词:
这就是BRCA BRCA.基因分析是基因分析.人力资源副主任HRD卵巢癌是发生在卵巢中的癌症.

更多相关视频

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose13:04

In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose

Published on: October 14, 2015

13.0K

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.8K